Vincent Bollors Media Influence Sparks Concerns EU Fund Proposal Could Safeguard Democratic Diversity ColgatePalmolive India Reports Marginal Q4 Profit Decline FullYear FY26 Revenue Dips to Rs 6124 Crore Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Endurance Technologies IPO Opens Company Aims to Raise 1162 Crore via Public Issue TNR Gold Secures C42 Million Strategic Investment from Altius Cricket Fandom Goes Digital Fan Tokens Could Be the Next Big Play in Sports Engagement WSO Q1 2026 Earnings EPS Surpasses Estimates by 933 Stock Declines Marginally AEON Q4 2025 Earnings Deep EPS Miss Amid PreRevenue Stage CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6 CC Q1 2026 Earnings Strong EPS Surprise Despite Unreported Revenue GKOS Q1 2026 Earnings Narrowerthanexpected loss fails to lift shares CNB Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 74 as Stock Declines Here Group Limited Slides to 235 Support Test in Focus Skillsoft Corp SKIL Rallies 237 as Shares Test Key Resistance Area Wabash National WNC Edges Higher Testing Support Levels Amid Modest Uptick BlackRock Science and Technology Trust BST Gains 23 as Tech Tailwinds Support Momentum Franklin Limited Duration Income Trust FTF Edges Higher as Yield Seekers Reassess Rate Outlook Home Depot Comparable Sales Catch Up to Lowes Could Signal Stock Performance Shift Oxford Square Capital Corp Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Expand Energy EXE Edges Higher as Natural Gas Markets Show Signs of Stability CHT Q1 2026 Earnings EPS Misses Estimates Slightly Stock Declines Modestly MBINL Q1 2026 Earnings EPS Beats Estimates by 502 Amid Strong Operational Performance Sony Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Declines PCG Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency SABS Q1 2026 Earnings EPS Misses Estimates Stock Rises on Pipeline Progress TXNM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges LTRN Q1 2026 Earnings EPS Beat Expectations as Biotech Focuses on Pipeline Progress